Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-x L but not Bcl-2 INTRODUCTION
Programmed cell death or apoptosis plays an important role in the development and homoeostasis of multicellular organisms by triggering an intrinsic cellular death programme when cells are damaged, infected or no longer receiving survival signals from their extracellular environment [1, 2] . The Bcl-2 family of proteins consists of anti-and pro-apoptotic molecules that control a critical intracellular checkpoint within an evolutionarily conserved cell-death pathway [3] . The relative ratios between proand anti-apoptotic members of this family determine the ultimate sensitivity or resistance of cells to apoptotic signals [4] . Many of the Bcl-2-family proteins are capable of interacting with each other through a complex network of homo-and hetero-dimers. In order to avoid a suicidal fate, cells require continuous survival signals from their surface receptors. A number of survival factors, such as insulin-like growth factor, platelet-derived growth factor, nerve growth factor and interleukin-3 (IL-3), promote cell survival at least in part through a mechanism of post-translational modification for inactivating pro-apoptotic Bcl-2-family members and preventing their interaction with anti-apoptotic Bcl-2-family members [5] .
The Bad protein is a pro-apoptotic member of the Bcl-2 family that can bind to anti-apoptotic proteins such as Bcl-2 and Bcl-x L and promote cell death [6] . Recent data indicate that the ability of Bad to heterodimerize with Bcl-2 or Bcl-x L and to promote apoptosis is modulated by mechanisms that control the state of phosphorylation of this pro-apoptotic protein [5, 7, 8] . As a large proportion of Bcl-2 and Bcl-x L protein molecules are anchored in the outer membranes of mitochondria with orientation toward the cytosol, phosphorylation of Bad impairs its binding to Bcl-x L and results in a translocation of Bad from the surface of Abbreviations used : TM, transmembrane ; HM, heavy membrane ; BH, Bcl-2 homology ; FCS, fetal calf serum ; IL-3, interleukin-3. 1 To whom correspondence should be addressed (e-mail wanghg!moffitt.usf.edu).
phosphorylation of Bad at Ser-136 and Ser-155, sequestering this protein in the mitochondrial membranes. When the N-terminal regions of Bcl-2 and Bcl-x L were swapped with each other, the Bcl-x L (N)-Bcl-2 chimaeric protein (containing the N-terminal region of Bcl-x L ) failed to prevent Bad phosphorylation in cells and was unable to block the cytosolic distribution of this proapoptotic protein. Additional experiments with the Bcl-2(N)-Bcl-x L chimaeric protein (containing the N-terminal region of Bcl-2) indicated that, although the N-terminal region of Bcl-2 is necessary, it is not sufficient for sequestering Bad in the mitochondrial membranes. These observations suggest that growthfactor-mediated phosphorylation of Bad contributes to the cytoprotective function of Bcl-x L but not Bcl-2.
Key words : apoptosis, IL-3, mitochondria, subcellular fractionation, translocation. mitochondria to the cytosol [9] . At least three sites on Bad (Ser-112, Ser-136 and Ser-155 in the murine protein) can become phosphorylated by growth factors through activating survival kinases such as Raf-1 when targeted to mitochondria [7, [10] [11] [12] , Akt\protein kinase B [13] [14] [15] , protein kinase A [16] [17] [18] [19] [20] , the p21-activated kinases [21] or the mitogen-activated protein kinase-activated kinase RSK [18, 22] . Ser-112 and Ser-136 of the mouse Bad protein lie within the potential 14-3-3 binding sites [23] . Consistent with this, phsophorylation of Ser-112 and Ser-136 results in Bad sequestration by cytosolic 14-3-3-family proteins [9] . In contrast, Ser-155 is localized in the BH3 domain of Bad (where BH means Bcl-2 homology) that is embedded within the surface pocket created by the combination of BH1, BH2 and BH3 domains of dimerization partners Bcl-2 and Bcl-x L [24] , thus phosphorylating Ser-155 must require a conformational change in the Bad complexes. However, it is unclear how phosphorylation of Bad causes its dissociation from Bcl-2 and Bcl-x L , though it has been proposed that Ser-136 phosphorylation of Bad recruits 14-3-3 proteins and weakens the association between Bad and Bcl-x L , accessing Ser-155 kinases for complete disruption of the Bad-Bcl-x L complex [17] . Here we provide evidence that phosphorylation of Bad by survival-factordependent kinases impairs its binding to Bcl-x L but not Bcl-2 and that differences in the BH4 and loop regions of Bcl-2 and Bcl-x L contribute to the phenotypes of these proteins.
MATERIALS AND METHODS

Plasmid constructions
The pSFFV-Bcl-x L plasmid was generated by subcloning the human Bcl-x L cDNA into the pSFFV-Neo vector [25] using were transfected with FLAG-Bad-producing plasmid (BAD C3 etc., where Cx refers to the subclone number) or parental vector (Puro) DNA using electroporation. In (A) and (C), transfected FL5.12 cells were subcloned by limiting dilution and cell lysates were prepared for SDS/PAGE and immunoblot analysis using anti-FLAG M2 monoclonal antibody and polyclonal rabbit antisera specific for Bcl-x L or Bcl-2. In (B) and (D), the same subclones were cultured for various times in the absence of IL-3 and the percentage of variable cells was determined by Trypan Blue dye exclusion (meanspS.D. ; n l 3).
the EcoRI site. For construction of pcDNA3-Bcl-2(N)-Bcl-x L chimaeric plasmid (containing the N-terminal region of Bcl-2), the HindIII-BlpI fragment of human Bcl-2 cDNA was ligated with the SmaI-EcoRI fragment of human Bcl-x L cDNA, then subcloned into the HindIII\EcoRI-digested pcDNA3 vector (Invitrogen). The Bcl-x L (N)-Bcl-2 chimaera (containing the N-terminal region of Bcl-x L ) was generated by subcloning the EcoRI-SmaI fragment of human Bcl-x L cDNA and the BlpI-XbaI fragment of human Bcl-2 cDNA into the EcoRIdigested pSFFV-Neo vector after blunt-end treatment.
Cell culture and transfection
293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) FCS, 50 units\ml penicillin G and 50 µg\ml streptomycin. FL5.12 cells were maintained in RPMI 1640 medium supplemented with 10 % fetal-calf serum (FCS), 15 % (v\v) conditioned medium from WEHI 3B cells, as a source of IL-3, and antibiotics. 293T cells were transfected by calcium phosphate precipitation and FL5.12 cell lines were transfected by electroporation as described previously [26] .
Cell viability assay
Stably transfected FL5.12 cells were washed three times with PBS and cultured in RPMI 1640 medium containing 10 % FCS without IL-3 for 4 days. The cell viability was determined by Trypan Blue dye exclusion at each time point.
Preparation of subcellular fractions
The subcellular fractions were prepared as described in [10] with some modifications. Namely, 2i10) cells were suspended in 2 ml of hypotonic buffer (3.3 mM Hepes, pH 7.5, 1.7 mM KCl, 0.25 mM MgCl # , 0.17 mM EGTA and 0.17 mM EDTA) containing 3.3 µg\ml aprotinin, 6.6 µg\ml leupeptin, 3.3 µg\ml pepstatin, 0.3 mM PMSF, 16.7 mM NaF, 66.7 µM Na $ VO % and 8.3 mM sodium β-glycerophosphate. After incubation on ice for 30 min, cells were homogenized with a Dounce homogenizer and centrifuged at 1000 g for 5 min at 4 mC to discard unbroken cells and nuclei. The resulting supernatant was centrifuged at 10 000 g for 10 min at 4 mC to obtain the heavy-membrane (HM) fraction (pellet). The resulting supernatant was then centrifuged for 30 min at 100 000 g at 4 mC to obtain the cytoplasmic fraction (supernatant).
Immunoblotting and immunoprecipitation analysis
Cells were lysed in Triton X-100 lysis buffer (10 mM Hepes, pH 7.5, 143 mM KCl, 5 mM MgCl # , 1 mM EGTA and 0.5 % Triton X-100) containing 2 µg\ml aprotinin, 5 µg\ml leupeptin, 1 µg\ml pepstatin, 0.2 mM PMSF, 50 mM NaF, 100 µM Na $ VO % and 25 mM sodium β-glycerophosphate. Immunoblotting and immunoprecipitation were carried out as described previously [27] . Inhibition of Bad translocation by Bcl-2
RESULTS
IL-3-induced Ser-112 phosphorylation frees Bad from Bcl-x L but not Bcl-2
To study the effects of Bad phosphorylation on its ability to bind to Bcl-2 and Bcl-x L , we transfected IL-3-dependent FL5.12 cell lines stably expressing Bcl-2 or Bcl-x L with plasmids encoding FLAG-tagged Bad. Several independent clones of FL5.12 transfectants with a wide range of FLAG-Bad protein levels were obtained and used to determine the association between expression of the Bad protein and promotion of apoptosis ( Figure  1 ). Following IL-3 withdrawal, a general correlation between higher levels of FLAG-Bad protein and faster cell-death kinetics was observed in FL5.12 clones co-expressing Bcl-x L ( Figure 1B) . In contrast, no significant differences in the viability of FL5.12 cells were observed among the Bcl-2-overexpressing clones, regardless of their relative levels of FLAG-Bad protein ( Figure  1D ). This result, together with the previous report [6] , indicates that the pro-apoptotic protein Bad nullifies the anti-apoptotic activity of Bcl-x L , but not that of Bcl-2.
Next, we performed subcellular fractionation experiments to examine the intracellular translocation of Bad in response to IL-3 stimulation. When cultured in the absence of IL-3, the FLAGBad protein was contained predominantly within the mitochondrion-enriched HM fraction, where Bcl-2 or Bcl-x L resides ( Figure 2 ). As reported previously [28] , Bcl-2 was mainly associated with membranes ( Figure 2B ) whereas a small proportion of Bcl-x L was localized in the cytosolic fraction (Cyt, Figure 2A ). Immunoblot analysis with antibodies specific for the mito-
Figure 2 IL-3-induced Ser-112 phosphorylation of Bad triggers Bad dissociation from Bcl-x L but not Bcl-2
FL5.12-Bcl-x L /FLAG-Bad (A) and FL5.12-Bcl-2/FLAG-Bad (B) transfectants were cultured in the absence of IL-3 for 8 h and 12 h, respectively, prior to stimulation with or without 100 ng/ml recombinant mouse IL-3 (BioSource International) for 30 min. Then, cells were fractionated into cytosolic (Cyt) and HM fractions, which were normalized for protein content and subjected to SDS/PAGE and immunoblot analysis (30 µg of protein/lane) with antibodies specific for FLAG-epitope, pSer112-Bad (BioSource International), pSer136-Bad (New England BioLabs), pSer155-Bad (New England BioLabs), Bcl-x L , Bcl-2 or COX IV (cytochrome c oxidase complex IV ; Molecular Probes). In addition, FLAG-Bad-transfected 293T cell lysates were used in lanes 5 (CNTL) as positive controls for the anti-phospho-Bad antibodies.
chondrial protein Cox IV was used as a control for the fractionation procedure. IL-3 stimulation resulted in a slowermigrating form of FLAG-Bad in gels as a doublet (Figure 2A , lane 1), indicating the presence of phosphorylated Bad protein.
To map the phosphorylation sites in Bad protein, we employed the anti-phospho-Bad antibodies that have been shown to specifically recognize phosphorylated Ser-112, Ser-136 or Ser-155 residues in the murine Bad [17, 18] . As shown in Figure 2 , Bad was phosphorylated at Ser-112, but not Ser-136 and Ser-155, in response to IL-3 stimulation. Ser-112-phosphorylated Bad was detected in both the HM fraction and the cytosolic fraction of FL5.12 cells co-expressing FLAG-Bad and Bcl-x L (Figure  2A) , suggesting that phosphorylation of Bad by IL-3 disrupts its binding to Bcl-x L . In contrast, surprising results were obtained for FL5.12 cells co-expressing FLAG-Bad and Bcl-2, in which Ser-112 phosphorylation of Bad was observed only in the HM fraction and IL-3 stimulation failed to induce the translocation of Bad from the mitochondria to the cytosol ( Figure 2B ).
Only cytosolic Bad binds to 14-3-3 protein
To determine whether phosphorylation-induced Bad dissociation for Bcl-x L requires the recruitment of 14-3-3 proteins, we performed co-immunoprecipitation experiments using subcellular fractions prepared from FL5.12 transfectants. As shown in Figure 3 (A), 14-3-3 was exclusively co-immunoprecipitated with FLAG-Bad in the cytosolic fraction prepared from IL-3-stimulated Bcl-x L \FLAG-Bad FL5.12 cells, consistent with the previous report [9] that phosphorylated Bad translocates to
Figure 3 IL-3-stimulation-induced Bad dissociation from mitochondria does not require the recruitment of 14-3-3
Each subcellular fraction (100 µg) prepared from FL5.12-Bcl-x L /FLAG-Bad (A) or FL5.12-Bcl-2/FLAG-Bad (B) transfectants was subjected to immunoprecipitation (IP) with anti-FLAG M2 monoclonal antibody, followed by immunoblot analysis with the indicated polyclonal antibodies. In (C) and (D), stably transfected FL5.12 cells were cultured in the presence or absence of IL-3 and lysed in Triton X-100 lysis buffer. Whole-cell lysates (500 µg) were used for immunoprecipitation with monoclonal antibodies specific for Bcl-x L or Bcl-2 and analysed by immunoblotting with the indicated polyclonal rabbit antisera. Cyt, cytosolic fraction. the cytosol where it binds to 14-3-3 molecules. IL-3 simulation induced phosphorylation of Bad Ser-112 on mitochondria, but did not recruit 14-3-3 to the mitochondrial Bad complexes ( Figures 3A and 3B, lanes 1) . Moreover, Ser-112-phosphorylated Bad could associate with both Bcl-x L and Bcl-2, although less Ser-112 phospho-Bad was detected in Bcl-x L immune complexes compared with that found in Bcl-2 immunoprecipitates ( Figures  3C and 3D) . These results suggest that phosphorylation of Ser-112 weakens the association of Bad with Bcl-x L but not Bcl-2 and that 14-3-3 molecules may not be involved in this process.
Bcl-2 inhibits Bad phosphorylation at Ser-136 and Ser-155 in 293T cells
To further confirm the differences in Bcl-2 and Bcl-x L for controlling Bad phosphorylation in cells, 293T cells were transiently co-transfected with plasmids encoding FLAG-Bad and Bcl-2 or Bcl-x L . Immunoblot analysis showed that phosphorylation of Bad at Ser-136 and Ser-155 was dramatically reduced in 293T cells co-expressing Bcl-2 ( Figure 4, lane 2) . In contrast, expression of Bcl-x L had no effect on Bad phosphorylation in 293T cells compared with the control transfection (Figure 4,  lanes 1 and 3) .
The N-terminal region of Bcl-2 is critical for sequestering Bad in mitochondria
Both Bcl-2 and Bcl-x L contain four conserved domains (BH1, BH2, BH3 and BH4) as well as a loop region and a transmembrane (TM) domain [3] . To gain further insights into these molecules, we calculated theoretical isoelectric point (pI) values for each of the conserved domains in the human Bcl-2 and Bclx L proteins. As shown in Table 1 , the pI values between the N-terminal regions of Bcl-2 and Bcl-x L , in which the BH4 and loop domains reside, are apparently different, with 8.17 for Bcl-2 and 4.41 for Bcl-x L . In contrast, there is relatively no difference in pI values between the remaining C-terminal parts of the proteins from BH3 through to the TM domain.
We hypothesized that differences in pI values between the N-terminal regions of Bcl-2 and Bcl-x L reflect their characters in controlling the subcellular localization of Bad in cells. To test this hypothesis, we made chimaeric Bcl proteins by exchanging their N-terminal regions with each other. The pI values for these chimaeric molecules, Bcl-2(N)-Bcl-x L and Bcl-x L (N)-Bcl-2, were very similar to those of Bcl-2 and Bcl-x L , respectively (see Table  1 for details).
Next, we determined the effects of these Bcl chimaeric proteins on the intracellular distribution and phosphorylation of the Bad Inhibition of Bad translocation by Bcl-2
Figure 4 Bcl-2 prevents Bad phosphorylation in 293T cells
293T cells were transiently transfected with the indicated plasmids encoding FLAG-Bad, Bcl-2 or Bcl-x L . Cells were lysed 24 h later and subjected to SDS/PAGE and immunoblot assay with the indicated specific antibodies. 
protein in 293T cells. As shown in Figure 5 (B), FLAG-Bad was mainly distributed in the cytosolic fraction and phosphorylated at serines 112, 136 and 155 in 293T cells expressing FLAG-Bad alone. When co-transfected with Bcl-x L , FLAG-Bad was apparently detected in both cytosolic and HM fractions. In this case, the cytosolic FLAG-Bad protein was also phosphorylated at all of these three serine residues, whereas no or very little phosphorylated Bad was detected in the HM fraction. Strikingly, FLAG-Bad was predominantly detected in the HM fraction of 293T cells overexpressing Bcl-2, even in the presence of growth factors. However, when co-transfected with Bcl-x L (N)-Bcl-2, FLAG-Bad was distributed and phosphorylated essentially the same as that in 293T cells co-expressing Bcl-x L , suggesting that Bcl-2 is converted into Bcl-x L by swapping its N-terminal regions with Bcl-x L . In the case of co-expression of Bcl-2(N)-Bclx L , FLAG-Bad was also phosphorylated and distributed in both fractions, although a large proportion of FLAG-Bad was detected in the HM fraction compared with the cytosolic fraction. These results indicate that the N-terminal region of Bcl-2 is necessary but not sufficient for inhibiting Bad phosphorylation and its subsequent translocation to the cytosol in response to survival signals. These data, together with the results from FL5.12 transfectants, suggest that growth factor-induced phosphorylation of Bad impairs its binding to Bcl-x L , whereas Bcl-2 prevents Bad phosphorylation, especially at Ser-136 and Ser-155, sequestering it in the outer membranes of mitochondria.
DISCUSSION
The BH3-only death promoter Bad interacts with anti-apoptotic molecules Bcl-2 and Bcl-x L and promotes apoptosis [6] . Phosphorylation of Bad is induced by growth factors such as IL-3, insulin-like growth factor 1 and platelet-derived growth factor, disrupting its interaction with Bcl-x L and abrogating its proapoptotic effects in cells [9, 13] . Unlike the Bad-Bcl-x L association, we show here that the binding of Bad to Bcl-2 is not mediated by growth-factor-dependent kinases. In response to IL-3 stimulation, Bad was phosphorylated at Ser-112 but not Ser-136 and Ser-155, as demonstrated by immunoblotting with anti-phosphoBad antibodies. In the absence of IL-3, Bad was predominantly detected in the mitochondrion-enriched HM fraction in which Bcl-2 and Bcl-x L reside. IL-3 stimulation resulted in the redistribution of Bad to the cytoplasm where it was captured by 14-3-3 proteins in FL5.12 cells co-expressing FLAG-Bad and Bcl-x L , consistent with the results of Zha et al. [9] . It has been proposed that phosphorylation of Bad Ser-136 is required for the recruitment of 14-3-3 proteins that weaken the interaction of Bad with Bcl-x L and increase the access of Ser-155 kinases to the Bad protein [17] . Thus Ser-155 phosphorylation of Bad is essential for completing its dissociation from the Bad-Bcl-x L complexes and subsequent translocation to the cytosol [17] [18] [19] [20] . However, at least in our FL5.12 cell lines, Ser-112 phosphorylation seems to be sufficient to induce the dissociation of Bad from Bcl-x L in response to IL-3 stimulation, but we cannot exclude the possibility that the anti-phospho-Bad antibodies used for this study are less sensitive for Ser-136 and Ser-155 detection. It should be noted, however, that all of these three serine residues in FLAGBad were strongly phosphorylated in 293T human embryonic kidney cells. Moreover, the data showing that 14-3-3 association with Bad occurred only in the cytosolic fraction argue that the recruitment of 14-3-3 to the Bad-Bcl-x L complex by Ser-136 phosphorylation may not be the primary mechanism used by IL-3 to disrupt the interaction between Bcl-x L and Bad. In contrast with Bcl-x L -expressing cells, Ser-112 phosphorylation of Bad was only detected in the HM fraction of FL5.12 cells overexpressing Bcl-2, and no Bad translocation occurred following IL-3 stimulation. This phosphorylation did not result in Bad association with 14-3-3 proteins when overexpressed with Bcl-2. In addition, co-immunoprecipitation experiments using anti-Bcl-2 and antiBcl-x L monoclonal antibodies showed that the association between Ser-112-phosphorylated Bad and Bcl-2 is more stable compared with that with Bcl-x L . Thus these results, together with the distinct distribution of Bad in 293T cells expressing Bcl-2 versus Bcl-x L , suggest that the protein complexes of Bad with Bcl-2 and Bcl-x L are structurally different. Bcl-2-family proteins contain up to four evolutionarily conserved domains : BH1, BH2, BH3 and BH4. Both Bcl-2 and Bclx L have all four BH domains, which are quite similar between these proteins, and they also have a TM domain near their Ctermini ( Figure 5A ) [3] . A region that lies between the N-terminal BH4 domain and the BH3 domain is designated as the loop domain or loop region, which is totally different between Bcl-2-family proteins ; it has been reported that modification of the loop domain could affect their anti-apoptotic activities [29] [30] [31] [32] . Furthermore, caspase cleavage of the loop region can convert anti-apoptotic Bcl-2 and Bcl-x L into Bax-like pro-apoptotic proteins [33, 34] . Although the X-ray and NMR structures of Bclx L have been reported [24, 35] , the structure of the loop region of this protein is not clear due to its flexibility.
We hypothesized that this loop region might be important for Bcl-2 and Bcl-x L to regulate Bad phosphorylation and intracellular translocation between cytoplasm and mitochondria. To demonstrate this hypothesis, we calculated the pI values for each domain in Bcl-2 and Bcl-x L . The pI value is one of the calculable indices from primary protein sequence, which indicates acidity or alkalinity of a protein molecule in solution. Protein acidity or alkalinity affects protein-protein interactions. As we expected, there is no significant difference between the pI values of the wellconserved C-terminal half domains of Bcl-2 and Bcl-x L . However, the pI value of the loop region is quite different between Bcl-2 and Bcl-x L , indicating that the loop region dominates the pI values in these molecules. Indeed, the pI values were switched by swapping the N-terminal regions in which the loop domain resides. At least one of three serines, 112, 136 and 155, on mouse Bad can be phosphorylated in cells by survival-factor-dependent kinases, making this protein slightly acidic. It is possible that once Bad is phosphorylated the resulting acidic residue(s) facili-Inhibition of Bad translocation by Bcl-2 tates dissociation of Bad from Bcl-x L (pI l 4.86) but not Bcl-2 (pI l 6.49), as shown in Figure 6 . This model is supported by our findings that when the N-terminal regions were swapped with each other, the Bcl-x L (N)-Bcl-2 chimaeric protein (pI l 5.01) failed to inhibit Bad phosphorylation and was unable to sequester Bad in the outer membranes of mitochondria ( Figure 5 ). In addition, substitution of the N-terminal region of Bcl-2 partially converted Bcl-x L into a Bcl-2-like protein, suggesting that the Nterminal region of Bcl-2 is necessary but not sufficient to sequester Bad on the surface of mitochondria in the presence of growth factors.
Taken together, the observations described in this study indicate that Bcl-2 and Bcl-x L represent two distinct binding partners for the pro-apoptotic Bad protein and that the Nterminal region of Bcl-2 and Bcl-x L appears to be critical for controlling their interaction with Bad. Phosphorylation of Bad by growth factors induces Bad dissociation from Bcl-x L but has no effect on Bad-Bcl-2 complex formation. This may reflect the bioactivities of Bcl-2 and Bcl-x L , in that Bad counters the antiapoptotic function of Bcl-x L but not that of Bcl-2 in cells upon growth-factor deprivation. In other words, phosphorylation of Bad allows Bcl-x L but not Bcl-2 to gain anti-apoptotic function in cells, because Bad constitutively binds to and inhibits Bcl-2 regardless of the presence or absence of growth factors. Thus alterations in the ratios of Bad and Bcl-2 may modulate Bcl-2 protein activity and put tumour cells into a more vulnerable state for therapeutic benefit.
